Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

LENZ Therapeutics (LENZ) Return on Equity (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Return on Equity for 4 consecutive years, with 0.34% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 11.0% to 0.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.34% through Dec 2025, down 11.0% year-over-year, with the annual reading at 0.34% for FY2025, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 0.34% at LENZ Therapeutics, down from 0.29% in the prior quarter.
  • The five-year high for Return on Equity was 3.03% in Q1 2023, with the low at 0.95% in Q1 2024.
  • Average Return on Equity over 4 years is 0.2%, with a median of 0.27% recorded in 2024.
  • The sharpest move saw Return on Equity crashed -399bps in 2024, then surged 71bps in 2025.
  • Over 4 years, Return on Equity stood at 0.72% in 2022, then surged by 267bps to 1.21% in 2023, then crashed by -119bps to 0.23% in 2024, then plummeted by -49bps to 0.34% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.34%, 0.29%, and 0.26% for Q4 2025, Q3 2025, and Q2 2025 respectively.